Article in The Journal of allergy and clinical immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
NCT01186913 enrolling by invitationnot on this map
A Prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children With SCID Disorders (RDCRN PIDTC-6901)
TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2010 to 2028Enrolled690ConditionsSevere Combined Immunodeficiency (SCID), Leaky SCID, Omenn Syndrome, Reticular Dysgenesis
A Retrospective and Cross-Sectional Analysis of Patients Treated for SCID Since January 1,1968 (RDCRN PIDTC-6902)
TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2011 to 2023Enrolled1,007ConditionsSCID, ADA-SCID, XSCID, Leaky SCID
Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995
TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2014 to 2021Enrolled1,480ConditionsGranulomatous Disease, Chronic
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors at 5 institutions in 2 countries.
Elie HaddadDivision of Pediatric Immunology, Allergy and Rheumatology, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada; CHU Sainte-Justine Research Centre, Montreal, Quebec, Canada. Electronic address: elie.haddad@umontreal.ca.
Zoulfia AllakhverdiCHU Sainte-Justine Research Centre, Montreal, Quebec, Canada.
Linda M GriffithDivision of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
Morton J CowanDivision of Pediatric Allergy, Immunology, and Blood and Marrow Transplant, Benioff Children's Hospital, University of California San Francisco, San Francisco, Calif.
Luigi D NotarangeloDivision of Immunology and the Manton Center for Orphan Disease Research, Children's Hospital Boston, Boston, Mass; Harvard Stem Cell Institute, Harvard Medical School, Boston, Mass.
Centre Hospitalier Universitaire Sainte-Justine · CADana-Farber/Boston Children's Cancer and Blood Disorders Center · USNational Institute of Allergy and Infectious Diseases · USUCSF Benioff Children's Hospital · USUniversité de Montréal · CA
Funding
Training of Clinical Investigators in Primary Immune DeficienciesU54AI082973 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALECH, HARRY · 2009 to 2023
$23.3M
Data Management and Coordinating Center (DMCC)U54NS064808 · NINDS · UNIVERSITY OF SOUTH FLORIDA · PI KRISCHER, JEFFREY P · 2009 to 2013
$16.5M
Primary Immune Deficiency Treatment Consortium Annual Scientific MeetingR13AI094943 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PUCK, JENNIFER M. · 2011 to 2025
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Survey on retransplantation criteria for patients with severe combined immunodeficiency. · full record | OpenQuestion